Multicenter randomized trial of arsenic trioxide and Realgar‐Indigo naturalis formula in pediatric patients with acute promyelocytic leukemia: Interim results of the SCCLG‐APL clinical study

Intravenous arsenic trioxide (ATO) has been adopted as the first‐line treatment for acute promyelocytic leukemia (APL). Another arsenic compound named the Realgar‐Indigo naturalis formula (RIF), an oral traditional Chinese medicine containing As(4)S(4), has been shown to be highly effective in treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ming‐Hua, Wan, Wu‐Qing, Luo, Jie‐Si, Zheng, Min‐Cui, Huang, Ke, Yang, Li‐Hua, Mai, Hui‐Rong, Li, Jian, Chen, Hui‐Qin, Sun, Xiao‐Fei, Liu, Ri‐Yang, Chen, Guo‐Hua, Feng, Xiaoqin, Ke, Zhi‐Yong, Li, Bin, Tang, Yan‐Lai, Huang, Li‐Bin, Luo, Xue‐Qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282847/
https://www.ncbi.nlm.nih.gov/pubmed/30160789
http://dx.doi.org/10.1002/ajh.25271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282847/
https://www.ncbi.nlm.nih.gov/pubmed/30160789
http://dx.doi.org/10.1002/ajh.25271

Ejemplares similares